2018 International Congress Archives - Page 58 of 177

DAT-imaging and clinical phenotypes of Parkinson’s disease

S. Varanese, S. Ruggieri, N. Modugno (Pozzilli, Italy)
Daughter’s ataxia reveals father’s genetic Parkinsonism. The first reported case of Spinocerebellar ataxia -15 presenting with levodopa responsive hemi Parkinsonism

M. Ghaly, C. Wools, A. Evans, E. Storey (St Albans, Australia)
DBS neuromodulation reduces severe dystonic pain in children and young people

S. Perides, J.P. Lin, G. Lee, H. Gimeno, R. Selway, K. Ashkan, M. Kaminska (London, United Kingdom)
Decision making in Huntington’s disease

B. Heim, M. Peball, P. Ellmerer, C. Saft, S.M. von Hein, W. Poewe, K. Seppi, A. Djamshidian (Innsbruck, Austria)
Decreased amyloid-beta in patients with Idiopathic Parkinson’s Disease and white matter hyperintensities

I. Markaki, S. Klironomos, P. Svenningsson (Stockholm, Sweden)
Decreased blood beta-Glucosidase activity and GBA mutations in Dystonia

S. Schreglmann, D. Burke, A. Batla, N. Kresojevic, N. Wood, S. Heales, K. Bhatia (London, United Kingdom)
Decreased interhemispheric homotopic connectivity in Parkinson’s disease patients with freezing of gait: A resting state fMRI study

L. Li, Y. Yuan, K. Zhang (Nanjing, China)
Deep brain stimulation (DBS) for dyskinetic cerebral palsy: A pilot study

S. Duma, N. Mahant, A. Ha, S. Kim, A. Phu, K. Stewart, M-C. Waugh, N. Wolfe, D. Russell, B. Owler, M. Krause, V. Fung (Westmead, Australia)
Deep brain stimulation (DBS) of the caudal zona incerta improving gait stability and truncal tremor in a patient with essential tremor

W. Tse, J. Iseringhausen, B. Kopell (New York, NY, USA)
Deep brain stimulation and its efficacy using microelectrode recording

V. Rama Raju, R. Borgohain (Hyderabad, India)
Deep brain stimulation for choreoathetosis in cerebral palsy: Pallidal versus thalamic stimulation

M. Wolf, C. Blahak, A. Saryyeva, C. Schrader, J. Krauss (Mannheim, Germany)
Deep brain stimulation for monogenic Parkinson’s disease: A systematic review

T. Kuusimäki, J. Korpela, E. Pekkonen, M. Martikainen, A. Antonini, V. Kaasinen (Turku, Finland)
Deep brain stimulation in a patient with Spinocerebellar ataxia type 2 presenting as Parkinson’s disease: A case report

J. Im, Y. Lee, S. Paek, B. Jeon (Seoul, Republic of Korea)
Deep brain stimulation in Parkinson’s disease: From the stimulation of a nucleus to the stimulation of neuronal networks

A. Arévalo, L. López Manzanares, R. Manzanares, M.A. García-Pallero, M. Navas, P. Pastor, L. Vega Zelaya, CV. Torres Diaz. (Madrid, Spain)
Deep Brain Stimulation in Tourette Syndrome: Two illustrative cases

X. Garcia, J. Espinoza, G. Arango (Bogota, Colombia)
Deep brain stimulation matters in pediatric neurology – single-center experience

M. Freilinger, A. Zeitlberger, S. Siegert, R. Seidl, F. Alesch, G. Kranz, K. Novak (Vienna, Austria)
Deep Brain Stimulation of Globus Pallidus Internus Combined with Bilateral Anterior Capsulotomy for the Treatment of Tardive Dystonia in Patients with Refractory Schizophrenia

Y. Pan, C. Zhang, Y. Zhang, L. Wang, Z. Deng, S. Zhan, J. Zhang, Y. Li, B. Sun, D. Li (Shanghai, China)
Deep brain stimulation outcomes for primary and secondary dystonia

M. Carmona-Abellán, O. Parras, R. Valentí, J. Guridi, M. Alegre, R. Luquin-Piudo (Pamplona, Spain)
Deep brain stimulation: A Treatment Modality for Generalized Dystonia Secondary to Anoxic Brain Injury in Adults

P. Vittal, J. Rosenow, M. Nolt, J. Pallone, M. McGraw, A. Monette, L. Guzman, A. Shrivastava, M. Mercury, M. Rezak (Winfield, IL, USA)
Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound

U. Walter, P. Tsiberidou, M. Kersten, A. Storch, M. Löhle (Rostock, Germany)
Delayed-onset Edema Surrounding Deep Brain Stimulation Leads: Insights From A Case Series and Literature Review

Y. Hu (Guangzhou, China)
Deletion of GBA2 in neuronopathic Gaucher’s disease medaka can’t rescue the phenotype

E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)
Delivery of AAV alpha synuclein to a mouse and rat provides a useful model for the assessment of anti-parkinsonian efficacy of chronic inhibition of LRRK2

R. Hodgson, T. Parkkari, T. Martinez, M. Fell, D. Bryce, T. Heikkinen, A. Nurmi, T. Bragge, M. Taavitsainen, T. Lanz, M. Baptista (Wilmington, MA, USA)
Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan

W. Lin, CY. Wei, HJ. Chen (ChangHua, Taiwan)
Depression (BDI-II) in Parkinson’s disease: Prevalence, types, and variables associated to major, minor and subclinical depression in COPPADIS cohort

M. Aguilar, P. Pastor, M. Almeria, I. Alvarez, S. Arribas, I. Gonzalez, M. Sierra, J. Infante, A. Avila, M. Catalan, F. Alonso, C. Villanueva, L. Lopez, V. Nogueira, V. Puente, A. Crespo, J. Garcia, F. Damas, E. Pacheco, P. Martínez-Martin, D. Santos, G. Coppadis (Terrassa, Spain)
Depression and associated factors in nondemented Chinese patients with Parkinson’s disease

J. Zhu, L. Zhang (Nanjing, China)
Depression, apathy, fatigue in Parkinson with or without STN DBS

L. Al-Nakeeb, M. Panisset (Montreal, QC, Canada)
Depressive symptoms effect subjective sleep quality in Parkinson’s Disease with and or without cognitive disturbance

J. Zhu, L. Zhang (Nanjing, China)
Depressive symptoms may predict the future development of freezing of gait in patients with Parkinson’s disease: Findings from a 5-year prospective study

T. Herman, S. Shema Shiratzky, L. Arie, N. Giladi, J. Hausdorff (Tel Aviv, Israel)
Derivation and characterization of Parkinson’s disease related pattern using functional magnetic resonance imaging

W. Sako, T. Abe, S. Haji, N. Murakami, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)
Design and Status of the BIIB054 SPARK Trial

Parkinson Study Group, A. Siderowf (NY, USA)
Design of a Pharmacokinetics Study with Multiple Doses of Accordion Pill™ Carbidopa/Levodopa in Patients with Parkinson’s disease

C. Olanow, K. Kieburtz, J. Dubow, F. Stocchi, J. Meckler, N. Navon, R. Gendreau (Sarasota, FL, USA)
Design of a Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa for Parkinson’s Disease (PD) Patients Experiencing Motor Fluctuations

P. LeWitt, R. Gendreau, J. Meckler, N. Navon (West Bloomfield, MI, USA)
Determinants of absence of dyskinesia in Parkinson’s disease patients with treatment beyond 10 years

R. Ou, Y. Wu, Q. Wei, X. Yuan, Y. Hou, H. Liu, L. Zhang, Y. Chen, B. Cao, X. Chen, H. Shang (Chengdu, China)
Determinants of Bed Mobility Proficiency in Patients with Parkinson’s Disease: A Pilot Study

S. Taniguchi, N. D’Cruz, T. Osaki, M. Nakagoshi, A. Nieuwboer, T. Shimokawa (Kobe, Japan)
Determinates and predictors of quality of life improvements after subthalamic deep brain stimulation in Parkinson’s disease

F.T. Liu, L.Q. Lang, Y.J. Yang, J. Zhao, J. Wang, J.J. Wu (Shanghai, China)
Determination of falling direction in Parkinson’s disease patients using a wearable sensor

Y. Okuma, H. Mitoma (Izunokuni, Japan)
Determining the effect of the HNMT, STK39 and NMD3 polymorphisms on the incidence of Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese populations

Y.P. Chen, B. Cao, R.W. Ou, Q.Q. Wei, X.P. Chen, B. Zhao, Y. Wu, W. Song, H.F. Shang (Chengdu, People’s Republic of China)
Developing a Self-Administered Instrumented Motor Exam for Home-based Parkinson’s Disease Assessment Using Wearable Sensors

S. Patel, C. Demanuele, B. Ho, P. Wacnik, H. Zhang, T. Kangarloo, V. Ramos, S. Amato, D. Volfson, P. Bergethon, M. Erb (Cambridge, MA, USA)
Development of a biomarker for Parkinson’s disease by measuring alpha-synuclein oligomers in cerebrospinal fluid with ultrasonication-induced amyloid fibril formation

K. Kakuda, K. Ikenaka, K. Araki, Y. Kajiyama, M. So, H. Hayakawa, T. Omichi, K. Baba, K. Konaka, T. Tokuda, Y. Goto, H. Mochizuki (Suita, Japan)
Development of a system to measure the kinetic responses of parkinsonian animal model

G.T. Kim (InCheon, Republic of Korea)
Development of anti-amyloid drugs for Parkinson’s disease by combination screening of high-throughput in vitro assay and phenotype-based C. elegans system

K. Ikenaka, K. Araki, S. Sonoda, T. Takeuchi, Y. Nagai, Y. Goto, H. Mochizuki (Suita, Japan)
Development of evidence-based clinical practice guideline (CPG) of complementary and alternative medicine (CAM) for Parkinson’s disease (PD)

K.H. Cho, S.W. Kwon, S.H. Lee, T.H. Kim (Seoul, Republic of Korea)
Diabetes Mellitus Alters Resting State Functional Networks in Early-Stage Parkinson’s Disease without Dementia

R. Ye, T. Shen, L. Xu, X. Guan, M. Zhang, B. Zhang (Hangzhou, China)
Diagnostic accuracy and imaging correlates of the Free and Cued Selective Reminding Test for screening mild cognitive impairment in Parkinson’s disease

J. Pagonabarraga, A. Horta-Barba, J. Marín-Lahoz, S. Martinez-Horta, H. Bejr-Kasem, I. Aracil, J. Pérez-Pérez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)
Diagnostic Impact of Movement Disorders Subspecialty Consultations at a VA Hospital

B. Barton (Chicago, IL, USA)
Diagnostic potential of automated middle cerebellar peduncle volumetry in variants of multiple system atrophy

F. Krismer, K. Seppi, T. Potrusil, R. Steiger, I. Zucal, G. Göbel, G. Wenning, E. Gizewski, W. Poewe, C. Scherfler (Innsbruck, Austria)
Diagnostic tips from a case series of patients with Late Onset Tay Sachs disease

G.M. Riboldi, K. Anstett, H. Lau (New York, NY, USA)
Diagnostic utility of a targeted resequencing technique of next generation sequencing in detecting copy number changes in PARK2

NY. Kim, SK. Hong, YE. Kim, HI. Ma, YJ. Kim (Anyang, Republic of Korea)
Diagnostic value and capability of DaT (dopamine-transporter) SEPCT scan to assess clinically uncertain Parkinsonism Diseases as a single institutional experience in Kuwait Population

S. Al Tailji, M. Elgadafi1, W. Kamel, J. Al-Hashel (Kuwait, Kuwait)
Dielectric Properties of Blood Plasma Predict Cognitive Impairment in an Amyloid-Beta-Induced Rat Model of Alzheimer’s Dementia

E. Dalle, A. Lonappan, M. Mabandla, W. Daniels (Durban, South Africa)
Diencephalic mesencephalic junction abnormalities in adult-onset movement disorders

A.M. Crespo Cuevas, V. Puente, S. Medrano, L. Planellas, D. Vilas (Barcelona, Spain)
Dietary habits, motor and cognitive impairment in Parkinson’s Disease

A. Pilotto, MC. Rizzetti, m. Oppini, C. passeri, A. Alberici, R. Turrone, M. Cosseddu, D. Placidi, M. Turla, b. Borroni, R. Lucchini, A. Padovani (Brescia, Italy)
Difference in sleep disorders among Parkinson’s disease, cervical dystonia and patients with depression

S. Tomic, D. Degmecic, S. Milanovic, F. Gjoni, I. Dumencic, Z. Popovic, T. Gilman Kuric (Osijek, Croatia)
Differences in the Unified Dyskinesia Rating Scale based on age, Parkinson´s Disease and Dyskinesias duration

E. Cubo, S. Luo, S. Calvo, P. Martinez-Martín (Burgos, Spain)
Different Characteristics of Action Tremor in Essential Tremor and Tremor Associated with Dystonia

P. Panyakaew, S. Lee, M. Hallett (Bangkok, Thailand)
Differential glial and neuronal response in Lipopolysaccharide induced Parkinson’s disease model: Modulation with Apocyanin and Curcumin

N. Sharma, B. Nehru (Chandigarh, India)
Diffusion magnetic resonance imaging for predicting the severity of Progressive supranuclear palsy

X.A. Zhao, S.H. Lin, C.C. Tsai, Y.M. Wu, W.Y. Lin, Y.H. Weng, L.S. Lu, Y.L. Chen, J.J. Wang (Taoyuan City, Taiwan)
Diffusion tensor imaging of olfactory tract in Parkinson’s disease

P. Nigro, N. Tambasco, A. Chiappiniello, S. Simoni, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)
Diminished fMRI global signal differences between eyes closed and eyes open resting state in RBD and PD

J. Suescun, M. Schiess, L. Giancardo, R. Castriotta, T. Ellmore (Houston, TX, USA)
DIRECT DBS: A Prospective, Multicenter Clinical Study with Double-Blinding for a Directional Deep Brain Stimulation Lead – Intra-visit Impedance Changes

F. Steigerwald, J. Volkmann, C. Matthies, A. Dalal Kirsch, S. Chabardes, R. de Bie, PR. Schuurman, E. Moro, V. Fraix, S. Meoni, D. Blum, L. Juarez Paz, K. Wynants, N. Van Dyck (Würzburg, Germany)
DIRECT DBS: A Prospective, Multicenter Clinical Study with Double-Blinding for a Directional Deep Brain Stimulation Lead – Visualization of Optimal Directionally Stimulated Anatomy

F. Steigerwald, J. Volkmann, C. Matthies, A. Dalal Kirsch, S. Chabardes, R. de Bie, PR. Schuurman, E. Moro, V. Fraix, S. Meoni, D. Blum, L. Juarez Paz, K. Wynants, N. Van Dyck (Würzburg, Germany)
DIRECT DBS: A Prospective, Multicenter Clinical Study with Double-Blinding for a Directional Deep Brain Stimulation Lead – Therapeutic Windows with Directional Stimulation

F. Steigerwald, J. Volkmann, C. Matthies, A. Dalal Kirsch, S. Chabardes, R. de Bie, P. Schuurman, E. Moro, V. Fraix, S. Meoni, D. Blum, L. Juarez Paz, K. Wynants, N. Van Dyck (Würzburg, Germany)
Direction of Turning in Parkinson’s Disease: More Affected Side or Less Affected Side?

S.M. Cheon, J.W. Kim (Busan, Republic of Korea)
Directional DBS; clinical experience at Unit of Functional Neurosurgery. Ramón y Cajal University Hospital,Madrid, Spain

M. del Alamo, I. Martinez-Camacho, L. Cabañes, I. Regidor, M. Villadoniga, J. Garcia-de-la-Cruz, I. Avilés-Olmos (Madrid, Spain)
Directional DBS: A new algorithm to determine lead rotation

T. Dembek, M. Barbe, A. Hellerbach, M. Hoevels, J. Wirths, A. Horn, V. Visser-Vandewalle, H. Treuer (Cologne, Germany)
Directional deep brain stimulation in Parkinson’s disease guided by local field potentials

F. Alonso-Frech, C. Fernandez-Garcia, M. Monge, M.J. Catalan Alonso, G. Foffani (Madrid, Spain)
Directional Deep Brain Stimulation: First experiences in centers across the globe

T. ten Brinke, V. Odekerken, J. Dijk, P. vd Munckhof, P. Schuurman, R. de Bie (Amsterdam-Zuidoost, Netherlands)
Directional Lead Impedances and Their Possible Effects on Deep Brain Stimulation

L. Juarez Paz, A. Dalal Kirsch, F. Steigerwald, C. Matthies, S. Meoni, V. Fraix, T. Ten Brinke, R. de Bie, K. Wynants, D. Blum, N. Van Dyck, PR. Schuurman, E. Moro, S. Chabardes, J. Volkmann (Valencia, CA, USA)
Discrepancies in assessments of freezing of gait: Self-report, clinical, and physical therapy assessments

B. Bluett, E. Bayram, J. Longhurst, S. Banks, Z. Mari, I. Litvan (Las Vegas, NV, USA)
Discriminating Idiopathic PD Patients and Controls in PPMI Using Integrative Multi-Modal Neuroimaging Analysis with Graph Convolutions

F. Wang, X. Zhang, L. He, C. Henchcliffe (New York, NY, USA)
Disease Modeling of DYT1 Using Patient Induced Pluripotent Stem Cells

A. Dinasarapu, D. Sutcliffe, M. Zwick, H. Jinnah (Atlanta, GA, USA)
Disease Modeling of Lesch-Nyhan Disease Using Induced Pluripotent Stem Cells

D. Sutcliffe, A. Dinasarapu, M. Zwick, H. Jinnah (Atlanta, GA, USA)
Disease progression and survival of multiple system atrophy: A prospective French cohort study

A. Foubert-Samier, A. Pavy-Letraon, F. Guillet, C. Helmer, M. LeGoff, F. Tison, F. Rascol, C. Proust-Lima, W. Meissner (Bordeaux, France)
Disrupted Amplitude of Low-frequency Fluctuations and Causal Connectivity in Parkinson’s Disease with Apathy

Y. Shen, J. Li, Y. Yuan, X. Wang, M. Wang, J. Wang, H. Zhang, L. Zhu, K. Zhang (Nanjing, China)
Dissecting molecular signatures of X-linked dystonia-parkinsonism (XDP) through integrative genomics studies

A. Domingo, S. Sharma, A. Aneichyk, W. Hendriks, Y. Yadav, D. Shin, D. Gao, C. Vaine, B. Currall, N. Kulkarni, T. Multhaupt-Buell, E. Penney, M. Dy, C. Go, RD. Jamora, R. Rosales, M. Ang, U. Müller, C. Klein, P. Acuña, X. Breakefield, L. Ozelius, DC. Bragg, M. Talkowski (Boston, MA, USA)
Dissociate effect of dopaminergic therapy in reward expectation and prediction error in PD patients with comorbid impulse control disorder

JF. Martin-Rodriguez, A. Rodriguez-Baena, L. Garrote Espina, P. Alvarez Toledo, S. Jesus, C. Mendez Barrio, A. Adarmes Gomez, F. Carrillo Garcia, M. Carballo Cordero, P. Mir (Seville, Spain)
Dissociative effects of thyrotropin releasing hormone on classical cerebellar ataxic signs and cerebellar adaptation in patients with spinocerebellar degeneration

T. Shimizu, R. Hanajima, R. Tsutsumi, N. Tominaga, Y. Ugawa, K. Nishiyama (Sagamihara, Japan)
Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson’s disease

L. Boon, N. Prent, W. Potters, M. Caan, H. Berendse, R. de Bie, P. vd Munckhof, P. Schuurman, A. van Rootselaar (Amsterdam, Netherlands)
Distinct abnormality of movement-related cortical potential between patients with Holmes tremor and cerebellar degeneration

M.K. Lu, J.C. Chen, S.M. Liu, C.H. Tsai (Taichung, Taiwan)
Distinct Blood Leukocytes Expression Profiles of Long Non-coding RNAs and mRNAs in Parkinson’s disease patients

Y. Fan, Z. Xue (Wuhan, China)
Distinct effects of apathy and dopamine on effort-based decision making in Parkinson’s disease

C. Le Heron, O. Plant, S. Manohar, Y. Ang, M. Jackson, G. Lennox, M. Hu, M. Husain (Oxford, United Kingdom)
Distinct networks contribute to the dysexecutive and posterior cortical cognitive syndromes of cognitive impairment in Parkinson’s Disease

S. Lang, S. Jobert, B. Mejia-Constain, C. Degroot, A. Lafontaine, A. Hanganu, P. Bellec, O. Monchi (Calgary, AB, Canada)
Distinguishing isolated asymmetric limb tremor from essential tremor: An electrophysiological study

F. Gövert, J. Becktepe, F. Brugger, L. Rocchi, A. Garrido, B. Balint, R. Hannah, T. Walter, J. Rothwell, R. Elble, K. Bhatia, G. Deuschl (Kiel, Germany)
Distinguishing ON from OFF Motor State by Phone Attribute Codes in Patients with Parkinson’s Disease

K. Abedinpour, A. Asaei, M. Cernak, D. Milana, T. Advani, F. Pfister, U. Fietzek (Munich, Germany)
Distribution Characteristics of Limbs Discomfort in Restless Legs Syndrome

X. Li, L.Y. Ni, X.Y. Zhu, T.T. Wu, Y.C. Wu (Shanghai, China)
Does ‘DYT23’ exist? Report of a second family with adult- onset focal dystonia and a CACNA1AB mutation – causative or coincidental?

P. Agarwal, M. Desai, S. Ravat (Mumbai, India)
Does altering medication to avoid dyskinesia positively alters the breadth of the motor repertoire of patients with Parkinson’s disease? A pilot study

S. Bogard, E. Goubault, K. Lebel, C. Duval (Montreal, QC, Canada)
Does dopaminergic denervation of specific anatomical regions of the basal ganglia correlate with clinical features of Parkinsonism: A quantitative DaTscan study

M. Salgado, S. Aggarwal, J. Muller, S. Singh, D. Ney (Brooklyn, NY, USA)
Does having more children really delay Parkinson’s age of onset in women?

M. MacAskill, D. Myall, T. Pitcher, T. Melzer, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)
Does motor laterality affect the development of dyskinesia in patients with Parkinson’s disease?

S. Chung, H. Yoo, J. Oh, J. Kim, P. Lee, Y. Sohn (Seoul, Republic of Korea)
Does Niemann Pick Type C heterozygosity predispose to late-onset neurodegeneration?

T. Bremova, C. Sztatecsny, M. Moser, A. Rominger, T. Stephan, J. Havla, K. Hartmann, D. Clevert, M. Strupp, S. Schneider (Munich, Germany)
Does the Basal Ganglia Dysfunction Affect Pisa Syndrome in Parkinson’s Disease?

Y.E. Huh, W-H. Chung, J. Youn, J.H. Ahn, J.W. Cho (Seongnam, Republic of Korea)
Does the degree of improvement after deep brain stimulation surgery for Parkinson’s disease (PD) meet the patient’s expectations?

J. Candelario-Mckeown, M. Torkamani, H. Sheridan, A. Coutts, M. Hartigan, M. Salazar, P. Limousin, M. Hariz, L. Zrinzo, J. Hyam, F. Foltynie, M. Jahanshahi (London, United Kingdom)
Does the effect of continuous levodopa infusion treatment for Parkinson’s disease regress as the day progresses?

I. Thomas, M. Memedi, D. Nyholm, J. Westin (Borlange, Sweden)
Does the Parkinson’s Kinetigraph change clinical practice?

S. Jones, C. Grose, S. Mahon, T. Williams, C. Thomas, B. Mohamed (Cardiff, United Kingdom)
Dopaminergic and Metabolic Imaging in Parkinson’s Disease motor subtypes and their relations to parkinsonian tremor

J. Zhao, L. Li, P. Wu, J. Wang, C.T. Zuo (Shanghai, China)
Dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder

P. Wu, H. Yu, Z. Huang, C. Zuo (Shanghai, China)
Dopaminergic impairments following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin through inflammatory cytokines in rats

R. Shukla, R. Gupta, S. Goel, A. Pant, V. Khanna (Bhopal, India)
Dopaminergic medication changes affect cognitive, mood, and quality of life outcomes after STN DBS

D. Floden, O. Hogue, M. Saupe, R. Busch, K. Wilson, A. Ahmed (Cleveland, OH, USA)
Dopaminergic neurons in Substantia Nigra pars compacta code the vigor of movement sequences

M. Mendonça, J. da Silva, L. Hernandez, I. Castela, J. Obeso, R. Costa (Lisboa, Portugal)
Dopaminergic stem cells reside in the rostral migratory stream

K. Schweyer, C. Steiner, G. Höglinger, T. Rösler (Munich, Germany)
Dopaminergics are alternative for the treatment of Bell`s paralysis in acute period

A. Azimov, R. Sadykov, G. Rakhimbaeva, F. Azimov (Tashkent, Uzbekistan)
Double-blind controlled trial of Spectramax™ light therapy for the treatment of Parkinson’s disease patients on stable dopaminergic therapy

A. Videnovic, S. Rutten, W. Croft, H. Erickson, J. Groves, C. Havemann, T. Herrington, S. Hendrix, K. Kieburtz, Y. vander Werf, O. vanden Heuvel (Boston, MA, USA)
Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease

YL. Tang, J. Wang (Shanghai, China)
Driving performance of Huntington’s disease gene carriers

M. Jacobs, E. Hart, Y. Mejia Miranda, G.J. Groeneveld, J. van Gerven, R. Roos (Leiden, Netherlands)
Droxidopa and Midodrine Treatment Persistence in Patients with Orthostatic Hypotension

S. Kymes, K. Jackson, M. Widolff, C. Sullivan, L. Hewitt, S. Raj (Deerfield, IL, USA)
Dual Competition between the Basal Ganglia and the Cortex: 1 from Action-Outcome to Stimulus-Response

T. Boraud (Bordeaux, France)
Dual device aided therapy for patients with advanced Parkinson’s Disease: A case series

A. Faust- Socher, G. Yahalom, M. Kestenbaum, A. Hilel, S. Israeli-Korn, A. Thaler, H. Strauss, H. Shabtai, S. Hassin-Baer, N. Giladi, T. Gurevich, O. Cohen (Tel Aviv, Israel)
Dual task in the daily life of patients with Parkinson’s disease

K. Mejia (Lima, Peru)
Dual task walking differentially affects toe clearance in Lewy body disease: A contributor to dynamic falls risk?

L. Alcock, R. McArdle, L. Aubrook, B. Galna, A. Thomas, L. Rochester (Newcastle upon Tyne, United Kingdom)
Duration of response with abobotulinumtoxinA in cervical dystonia: Patient distribution results from two open label extension studies

R. Hauser, D. Truong, M. Jog, D. Grimes, P. Picaut, A. Mann (Tampa, FL, USA)
Dyskinesia management in COMT-naïve patients starting adjunctive therapy with opicapone: The BIPARK-I double-blind experience

J. Pagonabarraga, E. Tolosa, J. Ferreira, A. Lees, E. Arbe, J. Rocha, P. Soares-da-Silva (Barcelona, Spain)
Dyskinesia-hyperpyrexia syndrome (DHS) after sudden interruption of deep brain stimulation and increase of oral dopaminergic therapy: A case report

F. Dematteis, A. Cormio, C. Fronda, M. Lanotte, M. Zibetti, S. Amarù, L. Lopiano, M. Rizzone (Rivoli, Italy)
Dysphagia predicts poor outcome in late-stage Parkinson’s disease

M. Fabbri, D. Abreu, L. Guedes, M. Rosa, A. Antonini, M. Zibetti, L. Lopiano, J. Fereira, M. Coelho (Lisbon, Portugal)
Dyspnea in Parkinson’s disease: A biomarker of disease’s severity?

G. Baille, T. Perez, F. Machuron, L. Defebvre, C. Chenivesse, C. Moreau (Lille, France)
Dystonia ataxia (DYTCA) syndrome with prominent handwriting deterioration associated with ADCK3 mutation: two new cases and an overview of the literature

S. Galosi, T. Schirinzi, E. Bertini, R. Haas, F.M. Santorelli, V. Leuzzi, J.R. Friedman (Rome, Italy)
Dystonia, Tremor, and Dystonic Tremor

A. Shaikh, A. Rosen, L. Scorr, A. Cotton, R. Barbano, C. Testa (Cleveland, OH, USA)